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Maternal enterovirus infections during pregnancy may increase the risk of oﬀspring developing type 1 diabetes during childhood.
The aim of this study was to investigate whether gestational enterovirus infections increase the oﬀspring’s risk of type 1 diabetes
later in life. Serum samples from 30 mothers without diabetes whose oﬀspring developed type 1 diabetes between 15 and 25 years
of age were analyzed for enterovirus-speciﬁc immunoglobulin M (IgM) antibodies and enterovirus genome (RNA), and compared
to a control group. Among the index mothers, 9/30 (30%) were enterovirus IgM-positive, and none was positive for enterovirus
RNA. In the control group, 14/90 (16%) were enterovirus IgM-positive, and 4/90 (4%) were positive for enterovirus RNA (n.s.).
Boys of enterovirus IgM-positive mothers had approximately 5 times greater risk of developing diabetes (OR 4.63; 95% CI 1.22–
17.6), as compared to boys of IgM-negative mothers (P<. 025). These results suggest that gestational enterovirus infections may
b er e l a t e dt ot h er i s ko fo ﬀspring developing type 1 diabetes in adolescence and young adulthood.
Copyright © 2008 Maria Elfving et al. This is an open access article distributed under the Creative Commons Attribution License,
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
1. INTRODUCTION
Type 1 diabetes develops in genetically susceptible individu-
als as a result of progressive autoimmune destruction of β-
cells in the pancreas. The incidence of type 1 diabetes has
increased worldwide in recent decades [1–4]. The peak age
at onset is at 10 to 14 years of age, and while there is no
diﬀerence in the incidence between boys and girls [4, 5],
several studies have shown a gender diﬀerence after 15 years
of age with a male:female ratio of approximately 3:2 [5–
7]. The reason for this gender diﬀerence is not known but
it cannot be excluded that susceptibility to environmental
factors may contribute.
Severalstudies support thehypothesis thatpre-and peri-
natal exposures to environmental risk factors are signiﬁcant
in the development of type 1 diabetes. Advanced maternal
age at delivery, complications during delivery, delivery by
cesareansection,andbloodgroupincompatibilityarerelated
to increased risk of type 1 diabetes in childhood [8–12].
It is also thought that congenital rubella increases the risk
of type 1 diabetes later in life, especially in the second and
third decades [13–15] .E n t e r o v i r u si n f e c t i o n sa r eo n eo f
the main candidates for an environmental trigger of type 1
diabetes[16–20],andmaternalenterovirusinfectionsduring
pregnancy have also been associated with increased risk of
oﬀspring developing type 1 diabetes during childhood in the
age group 0–14 years [21–24].
We have previously reported that cord blood islet
autoantibodies did not aﬀect the risk for type 1 diabetes in2 Experimental Diabetes Research
15–30-year-old subjects [25]. Therefore, in this study, we
examined whether intrauterine exposure to enterovirus
infection in the 15–30-year-old ages was associated with an
increased risk of oﬀspring developing type 1 diabetes, also
with particular reference to possible gender diﬀerence.
2. MATERIALS AND METHODS
2.1. Studypopulation
The city of Malm¨ o, Sweden, has 270000 inhabitants who
are served by Malm¨ o University Hospital (U-MAS), its only
hospital. The vast majority of deliveries in Malm¨ ot a k ep l a c e
in the Department of Obstetrics at this hospital. Since 1970,
umbilical cord blood serum has been taken at delivery from
the majority of children born at Malm¨ o University Hospital
and stored, together with a maternal serum sample similarly
taken at delivery, at –20◦C. Among those children born from
April 1970 to July 1984, 38 later developed type 1 diabetes
between the ages of 15 and 30. They were identiﬁed using
the Diabetes Incidence Study in Sweden (DISS) Registry
and classiﬁcation of type 1 diabetes in the oﬀspring was
done by the physicians, using clinical data and laboratory
ﬁndings as detailed in the DISS-study [26]. Of the group,
32 had cord serum and a corresponding maternal serum
sample saved from the time of birth. Two of the thirty-
two mothers (6%) had type 1 diabetes and were excluded,
since only 3% of new onset type 1 diabetes patients have
a mother with the disease. Consequently, the study was
comprised of 30 mothers whose oﬀspring (14 males and 16
females) developed type 1 diabetes at a median age of 18
years (range 15.2–25.5). The median age of the mothers at
delivery was 25.8 years (range 19.7–34.8). Information about
the incidence of type 1 diabetes among the fathers was not
available.
The control group consisted of 90 maternal serum
samples, including three control mothers for each of the 30
casemothers,matchedbydateofdelivery.Themedianageof
the control group was 25.9 years (range 19.4–40.1). Three of
the control mothers, although they were matched for month
and day, gave birth in the following year. Altogether, there
were 52 males and 38 females born to the control mothers.
None of these children developed type 1 diabetes during the
follow-up time.
2.2. Enterovirusantibodies
All sera were subjected to blind analysis. Immunoglobulin M
(IgM) was measured using a capture enzyme immunoassay
(EIA),aspreviouslydescribed[27].Acocktailofheat-treated
Coxsackievirus B3, Coxsackievirus A16, and echovirus 11
was used as the antigen in this assay, making it broadly
reactive to diﬀerent enterovirus serotypes. Biotinylated
immunoglobulin G (IgG) class antibodies, puriﬁed from
the serum of rabbits immunized with sucrose-gradient
puriﬁed viruses (Coxsackievirus B3, Coxsackievirus A16,
and echovirus 11), were used as detection antibodies in the
laboratory. After washing, streptavidin-peroxidase conjugate
9534A (Bethesda Research Laboratories, Gaithersburg, Md,
USA) was added. The level of IgM was expressed as positive
(+) or negative (–). The cutoﬀ limit for IgM positivity was
three multiples of the background, which is the optic density
(OD) value when the serum layer is replaced by phosphate-
buﬀered saline [28]. Values exceeding the background by
f o u rt i m e so rm o r ew e r ec o n s i d e r e dh i g h l yp o s i t i v e .
2.3. EnterovirusRT-PCR
RNA was extracted according to the manufacturer’s protocol
by a QIAamp viral RNA kit (Qiagen, Hilden, Germany)
from 140μL of the serum. Enterovirus RNA was detected by
reverse transcription-polymerase chain reaction (RT-PCR)
and a subsequent hybridization step that detects practically
all enterovirus serotypes, as described elsewhere [29]. All
positive samples were conﬁrmed by repeated RT-PCR.
2.4. Statisticalanalysis
Nonparametric methods were applied. Group comparisons
were performed using the Mann-Whitney test. Four ﬁeld
tables displaying the frequencies of study groups were
analyzed by means of Fisher’s exact test. Logistic regression
analyses were also performed. A two-tailed P value <.05 was
considered statistically signiﬁcant. The statistical analyses
were carried out with the standard statistical package (SPSS)
for Windows, V15.0 (SPSS Inc, Chicago, Ill, USA).
3. RESULTS
The prevalence of enterovirus IgM in sera taken at delivery
from mothers of children who developed type 1 diabetes
and from control mothers is given in Table 1. There was
no signiﬁcant diﬀerence in ages between the groups of
mothers. The prevalence value of enterovirus IgM was
higher in the mothers whose oﬀspring developed type 1
diabetes, as compared to control mothers, but the diﬀerence
did not reach statistical signiﬁcance (P<. 11) (Table 1).
Among the mothers of oﬀspring with diabetes, 9/30 (30%)
were enterovirus IgM-positive, and 5/30 (17%) had high
IgM titers. None was positive for enterovirus RNA. In the
control group, 14/90 (16%) were enterovirus IgM-positive,
8/90 (9%) had high titers, and 4/90 (4%) were positive
for enterovirus RNA. No signiﬁcant diﬀerences were found
between the groups (Table 1).
The gender of the child did inﬂuence the risk of diabetes
followingmaternalenterovirusinfection(Table 2).Inlogistic
regression controlling for mother’s age and the interaction
between IgM-positivity and gender we found that boys
born to IgM-positive mothers showed an increased risk
of developing type 1 diabetes (odds ratio [OR] 4.63; 95%
conﬁdence interval [CI] 1.22–17.6; P<. 025), as compared
to boys of IgM-negative mothers. No such increased risk
was found in girls born to IgM-positive mothers (OR 0.21;
95% CI 0.03–1.56). Mother’s age was included but was
not a signiﬁcant predictor of developing type 1 diabetes.
The results were similar when logistic regression was done
without controlling for maternal age. The frequency ofMaria Elfving et al. 3
Table 1: Enterovirus ﬁndings in serum samples taken at delivery from mothers whose children developed type 1 diabetes in adolescence and
young adulthood (Fisher’s exact test).
Index mothers (n = 30) Control mothers (n = 90) P value
Positive n (%) Negative n (%) Positive n (%) Negative n (%)
Enterovirus IgM 9 (30) 21 (70) 14 (16) 76 (84) 0.11
Enterovirus IgM high titers 5 (17) 25 (83) 8 (9) 82 (91) 0.31
Enterovirus RNA 0 30 (100) 4 (4) 86 (96) 0.57
maternal enterovirus IgM with regard to gender of the
oﬀspring is given in Table 3.
4. DISCUSSION
This study analyzed the correlation of maternal enterovirus
infectionsduringpregnancyandthefutureriskoftype1dia-
betes occurring in the oﬀspring. The presence of enterovirus
antibodies (IgM) and enterovirus genome (RNA) was
analyzed by means of stored serum samples obtained at
delivery from 30 mothers without diabetes whose oﬀspring
subsequently developed type 1 diabetes during adolescence
or young adulthood. Comparable samples were taken from
90 matched control mothers. The mothers of the oﬀspring
who later developed type 1 diabetes were carefully matched
to control mothers and the two groups were expected to
be exposed to a similar infectious environment during
pregnancy. The strength of our study is that the countywide
DISS registry [26] made it possible to identify not only the
oﬀsprings who developed diabetes but to ensure that none of
the children of the control mothers had acquired the disease.
The study is explorative due to the limited study cohort, but
it is unique as the serum samples used were obtained from
mothers who delivered their children as long as 30 years ago
in the same hospital.
We observed a diﬀerence in the presence of enterovirus
IgM between the patient and control groups, although it did
not reach statistical signiﬁcance. However, our study indi-
cated that maternal enterovirus infection was a signiﬁcant
riskfactorforthedevelopmentofdiabetesinboys,butnotin
girls.Thisﬁndingsuggeststhatboysmaybemoresusceptible
to the diabetogenic eﬀect of enteroviruses than girls during
the prenatal period. Prospective studies such as the ongoing
DiPiS [30]a n dT E D D Y[ 31] studies will be needed to fully
establish if maternal enterovirus infections contribute to the
gender diﬀerence in 15–25 year old type 1 diabetes patients.
E n t e r o v i r u sR N Aw a so n l yo b s e r v e di naf e wc o n t r o l
mothers. PCR of enterovirus is known to be positive in
serum only for a period between a few days and 1-2 weeks
during viremia. Therefore, a larger number of mothers who
gave birth to children developing type 1 diabetes as 15–30
year olds would be needed to fully explore the possible role
of gestational infections in this age group. However, while
PCR analysis can reﬂect an infection in its acute stage, IgM
antibodies persist much longer, allowing one to detect an
infection for a few months. In addition, the extended storage
of the samples, coupled with the fact that those of the patient
mothers were exposed to an additional thawing, may have
caused a bias in the PCR analysis. It has also been suggested
that cellular elements in blood sequester enteroviruses [32]
and that whole blood might be better for PCR analysis.
Some earlier reports have shown an association between
maternal virus infection during pregnancy and diabetes later
in life. Congenital rubella increased the risk of diabetes in
the second and third decades of life [13–15], indicating
the possibility of an extensive time lag. Other studies have
suggested that gestational enterovirus infections may be a
precursor of diabetes in young children [21–23]. In one of
these studies, the levels of enterovirus antibodies were found
to be elevated in the mothers of children who developed
type 1 diabetes before the age of three years [21]. In another
study tending to corroborate these results, mothers whose
children developed type 1 diabetes before age 15 showed an
elevated number of enterovirus infections during pregnancy,
compared to controls [24]. A case of neonatal diabetes with
evidence of maternal enterovirus infection during pregnancy
has also been reported [33]. It is known that enterovirus
infectionsshowseasonalvariation[19].Inananalysissuchas
ours it is possible that controls matched for time of sampling
also have been aﬀected. Their virus antibodies may therefore
rather mask a relationship between gestational enterovirus
infection and development of type 1 diabetes.
A research project using a larger cohort than those cited
above tested for the presence of enterovirus IgM in more
than 900 mothers of children who developed type 1 diabetes.
Controlmotherswerecarefullymatchedbythesamemethod
employed in our study [34]. No signiﬁcant diﬀerence
appeared between case and control groups. However, the
samples in that study were taken at the end of the ﬁrst
trimester,thusrevealingonlyinfectionsthatoccurredduring
the initial three months of pregnancy. This diﬀers from
our study, where samples were taken at delivery, enabling
an IgM assay to detect infections arising during the last
two trimesters of pregnancy. In addition, the present study
included children who were diagnosed with diabetes at an
older age than previously investigated. One report including
only 16 mothers, most of whom already had type 1 diabetes
from the German Multicenter BABY-DIAB study [35], did
not support the hypothesis of enterovirus infections during
pregnancy causing type 1 diabetes in oﬀspring.
We found an increased risk of developing type 1 diabetes
for boys born to IgM-positive mothers. A similar male
proclivity towards risk for β-cell damage in enterovirus-
induceddiabeteswasfoundearlierinmiceandinprospective
studies evaluating the risk eﬀect of postnatal enterovirus
infections [36, 37]. Other studies have also shown that boys4 Experimental Diabetes Research
Table 2: Odds ratio (OR) and 95% conﬁdence interval (CI) for developing type 1 diabetes (dependent variable in logistic regression) when
controlling for mother’s age, gender, interaction gender∗ IgM-positivity and IgM-positivity in oﬀspring.
95.0% CI for
BS E P< OR OR
Gender (M = 0, F = 1) 0.865 0.507 0.088 2.38 0.88–6.42
Gender∗IgM-positive (0/1) −1.556 1.022 0.128 0.21 0.03–1.56
Mother’s age −0.020 0.044 0.651 0.98 0.90–1.07
IgM-positive (0/1) 1.532 0.682 0.025 4.63 1.22–17.6
Constant −1.188 1.246 0.340 0.30
B = regression coeﬃcient of logistic regression elog (OR)
SE = standard error for B
OR = eB.
Table 3: Frequency of enterovirus IgM in mothers of oﬀspring developing type 1 diabetes and controls, divided with regard to gender.
Gender of oﬀspring Maternal enterovirus IgM n (%) Total n (%)
Positive Negative
Type 1 diabetes—males 6 (43) 8 (57) 14 (100)
Type 1 diabetes—females 3 (19) 13 (81) 16 (100)
Controls—males 7 (13) 45 (87) 52 (100)
Controls—females 7 (18) 31 (82) 38 (100)
might be more susceptible to enterovirus infections, possibly
due to having a weaker immune system [38]. HLA-DR
alleles, which mediate increased risk of type 1 diabetes (DR3
and DR4), have been associated with a stronger humoral
response to enterovirus antigens [39]c o m p a r e dt oH L A -
DR2. In our study, HLA genotypes were not available.
This might be a confounding factor, as patient and control
subjects ideally should be matched for both sex and HLA
type. It is possible that the observed diﬀerence between
patient and control subjects as the present study noted (also
reﬂected in approximately half of the previous studies cited)
indicates a genuine risk eﬀect, particularly in boys, which is
later modulated by several postnatal factors.
5. CONCLUSIONS
Taken together with previous studies, the present ﬁndings
suggest that maternal enterovirus infections during preg-
nancy may aﬀect the risk of type 1 diabetes in oﬀspring.
Our data suggest that the risk eﬀect is not pronounced and
may be relevant to boys in particular. The risk may also
be modulated by factors such as when the infection occurs
(early or late in pregnancy), the gender of the child, as well
as HLA and other susceptibility genes in the child and the
mother. Accordingly, large-scale studies covering the entire
period of pregnancy and taking into account children of all
ages with type 1 diabetes are warranted.
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